The epigenetic drugs space has witnessed a two-fold increase in Series A venture funding, with total deal value increasing to ...

AllazoHealth has introduced AI-enabled dynamic modular content to enhance initiation and adherence to medications.

Eli Lilly has received approval in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease.

Bavarian Nordic has received a $63m US contract to produce bulk product and final freeze-dried doses of the JYNNEOS ...

Generate:Biomedicines and Novartis have partnered for the discovery and development of protein therapeutics in multiple ...

Some counterfeits contain bacteria and have high impurity levels or different chemical structures to Lilly's FDA-approved ...

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...